摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3S,4R)-3-<(R)-1-(t-Butyldimethylsilyloxy)ethyl>-4-<(R)-1-(4,4-dimethyl-2-oxazolidone-3-carbonyl)ethyl>-2-azetidinone | 114341-89-8

中文名称
——
中文别名
——
英文名称
(3S,4R)-3-<(R)-1-(t-Butyldimethylsilyloxy)ethyl>-4-<(R)-1-(4,4-dimethyl-2-oxazolidone-3-carbonyl)ethyl>-2-azetidinone
英文别名
3-{(2R)-2-[(3S,4R)-3-[(1R)-1-tert-butyldimethylsilyloxyethyl]-2-oxoazetidin-4-yl]propionyl}-4,4-dimethyloxazolin-4-one;(3S,4R)-3-[(R)-1-(t-Butyldimethylsilyloxy)ethyl]-4-[(R)-1-(4,4-dimethyl-2-oxazolidone-3-carbonyl)ethyl]-2-azetidinone;3-[(2R)-2-[(2R,3S)-3-[(1R)-1-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]ethyl]-4-oxo-2-azetidinyl]-1-oxopropyl]-4,4-dimethyl-2-oxazolidinone;3-[(2R)-2-[(2R,3S)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-oxoazetidin-2-yl]propanoyl]-4,4-dimethyl-1,3-oxazolidin-2-one
(3S,4R)-3-<(R)-1-(t-Butyldimethylsilyloxy)ethyl>-4-<(R)-1-(4,4-dimethyl-2-oxazolidone-3-carbonyl)ethyl>-2-azetidinone化学式
CAS
114341-89-8
化学式
C19H34N2O5Si
mdl
——
分子量
398.575
InChiKey
FKDCIHFKKCAXJE-AAVRWANBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    27
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.84
  • 拓扑面积:
    84.9
  • 氢给体数:
    1
  • 氢受体数:
    5

SDS

SDS:bc46a377f161850590a3a3ac00e230f8
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Highly stereocontrolled synthesis of the 1β-methylcarbapenem key intermediate by the reformatsky reaction of 3-(2-bromopropionyl)-2-oxazolidone derivatives with a 4-acetoxy-2-azetidinone
    摘要:
    The key synthetic intermediate (4) of 1-beta-methylcarbapenems (1 approximately 3) was efficiently synthesized by employing highly stereocontrolled Reformatsky reaction (C4-alkylation) of 3-(2-bromopropionyl)-2-oxazolidone derivatives (6) with (3R,4R)-4-acetoxy-3-[(R)-1-(t-butyldimethylsilyloxy)ethyl]-2-azetidinone (5) in the presence of zinc dust followed by removal of 2-oxazolidone moieties. The best diastereoselectivity (beta:alpha = 95.5) could be realized by uses of sterically crowded achiral 2-oxazolidone derivatives such as 4,4-dimethyl-, 4,4,5,5-tetramethyl, and 4,4-dibutyl-5,5-pentamethylene-2-oxazolidone and higher reaction temperatures (refluxing tetrahydrofran). The remarkable diastereoselectivities observed for the Reformatsky reactions could be explained by means of the weakly chelating transition state models.
    DOI:
    10.1016/s0040-4020(01)87086-1
  • 作为产物:
    描述:
    (1S,5R,6R)-8-aza-5-methyl-2,4-dioxa-bicyclo<4.2.0>octan-3,7-dione 在 咪唑 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 反应 0.03h, 生成 (3S,4R)-3-<(R)-1-(t-Butyldimethylsilyloxy)ethyl>-4-<(R)-1-(4,4-dimethyl-2-oxazolidone-3-carbonyl)ethyl>-2-azetidinone
    参考文献:
    名称:
    (R)-3-羟基丁酸的1β-甲基卡巴培南关键中间体的高度立体选择性合成
    摘要:
    (3R,4R)-4-乙酰氧基-3-[(R)-1-(甲酰氧基)乙基] -2-氮杂环丁酮6可以通过[2 + 2 ]从(R)-3-羟基丁酸高立体选择性地制备氯磺酰基异氰酸酯与2H,4H-1,3-二恶英衍生物的]-环加成反应和伴随乙缩醛部分新裂解的Baeyer-Villiger反应。6与空间拥挤的3-(2-溴丙酰基)-2-恶唑烷酮衍生物的Reformatsky反应在连续的化学操作后很容易提供标题关键中间体。
    DOI:
    10.1016/s0040-4020(01)80578-0
点击查看最新优质反应信息

文献信息

  • A novel synthesis of the 1β-methylcarbapenem key intermediate employing the [2+2]-cycloaddition reaction of chlorosulfonyl isocyanate with a 4H-1,3-dioxin derivative
    作者:Yoshio Ito、Yuko Kobayashi、Shiro Terashima
    DOI:10.1016/s0040-4039(01)93817-1
    日期:1989.1
    synthetic route to the title compound was explored by featuring the [2+2]-cycloaddition reaction of chlorosulfonyl isocyanate with the 4H-1,3-dioxin derivative readily obtainable from methyl (R)-3-hydroxybutyrate, the Baeyer-Villiger reaction resulting in novel cleavage of the acetal moiety, and the Reformatsky reaction with sterically crowded 3-(2-bromopropionyl)-2-oxazolidone derivatives.
    通过特征在于氯磺酰基异氰酸酯与4 H -1,3-二恶英衍生物的[2 + 2]-环加成反应,可容易地从标题(Ba )的(R)-3-羟基丁酸甲酯中获得,来探索标题化合物的高度立体选择性合成路线。-Villiger反应导致新的乙缩醛部分裂解,以及与空间拥挤的3-(2-溴丙酰基)-2-恶唑烷酮衍生物发生Reformatsky反应。
  • Process for the preparation of 4-substituted azetidinone derivatives
    申请人:Takasago International Corporation
    公开号:US06340751B1
    公开(公告)日:2002-01-22
    Disclosed is a process for the preparation of a 4-substituted azetidinone derivative, which comprises reacting an azetidinone derivative and an amide compound in the presence of a magnesium compound such as those represented by the following formulas (II): and (IV): represented by the following formula (III): MgR5R6  (III) wherein R5 represents a C1-12 alkyl group, a C2-5 alkenyl group, a 5- to 8-membered alicyclic group which may be substituted by a lower C1-4 alkyl group, a phenyl group which may be substituted by a lower C1-4 alkyl group, a lower C1-4 alkoxy group or a halogen atom or a benzyl group which may be substituted by a lower C1-4 alkyl group, a lower C1-4 alkoxy group or a halogen atom, and R6 represents a halogen atom, a methanesulfonyloxy group, a benzenesulfonyloxy group, a p-toluenesulfonyloxy group, a trifluoromethanesulfonyloxy group, an acetoxy group which may be substituted by a halogen atom or a cyano group or an OR7 group (R7 representing a lower C1-4 alkyl group, a substituted or unsubstituted phenyl group or a substituted or unsubstituted benzyl group). The process provides an industrially excellent process for the preparation of a 4-substituted azetidinone derivative which permits the selective preparation of an intermediate for the synthesis of a carbapenem antibacterial agent having a desired 1-&bgr;′ configuration.
    揭示了一种制备4-取代氮杂环己酮衍生物的过程,包括在镁化合物的存在下,反应氮杂环己酮衍生物和酰胺化合物,所述镁化合物可由以下公式(II)和(IV)所表示:MgR5R6  (III)其中R5代表C1-12烷基,C2-5烯基,5-至8-成员的脂环基,该脂环基可以被低C1-4烷基取代,苯基,该苯基可以被低C1-4烷基,低C1-4烷氧基或卤素原子取代,苄基,该苄基可以被低C1-4烷基,低C1-4烷氧基或卤素原子取代;R6代表卤素原子,甲磺酰氧基,苯磺酰氧基,对甲苯磺酰氧基,三氟甲磺酰氧基,乙酰氧基,该乙酰氧基可以被卤素原子或氰基或OR7基(R7代表低C1-4烷基,取代或未取代的苯基或取代或未取代的苄基)取代。该过程提供了一种在工业上优秀的制备4-取代氮杂环己酮衍生物的过程,可允许选择性制备用于合成具有所需1-β'构型的碳青霉烯类抗菌剂的中间体。
  • A highly stereoselective synthesis of a key intermediate of 1β-methylcarbapenems employing the reformatsky reaction of 3-(2-bromopropionyl)-2-oxazolidone derivatives
    作者:Yoshio Ito、Shiro Terashima
    DOI:10.1016/s0040-4039(00)96930-2
    日期:——
  • CYHAKABA, DZYUN;TAMOTO, KATSUMI;SASAKI, AKIRA;TEHRASIMA, SIRO;ITO, JOSIO
    作者:CYHAKABA, DZYUN、TAMOTO, KATSUMI、SASAKI, AKIRA、TEHRASIMA, SIRO、ITO, JOSIO
    DOI:——
    日期:——
  • TEHRADZIMA, ATSURO;ITO, JOSIO;KAVABATA, TAKEHO;SAKAI, KUNIKADZU;XIYAMA, T+
    作者:TEHRADZIMA, ATSURO、ITO, JOSIO、KAVABATA, TAKEHO、SAKAI, KUNIKADZU、XIYAMA, T+
    DOI:——
    日期:——
查看更多

同类化合物

(6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 顺式-4-(2,2-二甲氧基乙基)-3-邻苯二甲酰-2-氮杂环丁酮 顺式-1-(对甲苯基)-3-苄氧基-4-(对茴香基)-氮杂环丁烷-2-酮 青霉酰聚赖氨酸 青霉素钾 青霉素钠 青霉素酶液体 青霉素杂质C 青霉素G衍生物 青霉素G甲酯 青霉素G甲酯 青霉素G-D7 青霉素 V 钠 阿那白滞素 阿莫西林钠 阿莫西林三水合物 阿莫西林 阿立必利D5 阿度西林 铜(2+)酞菁-29,30-二负离子-2-(二甲氨基)乙醇(1:1:1) 钾(2S,5R,6R)-6-[[2-[(E)-3-氯丁-2-烯基]巯基乙酰基]氨基]-3,3-二甲基-7-氧代-4-硫杂-1-氮杂双环[3.2.0]庚烷-2-羧酸酯 钠(6S,7R)-3-(羟基甲基)-7-甲氧基-8-氧代-7-[(2-噻吩基乙酰基)氨基]-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸酯 酞氨西林 萘夫西林杂质 苯磺酸,2-[(2-羟基-1-萘基)偶氮]-5-甲基-,盐(2:1)钡 苯氧乙基青霉素钾 苯唑西林钠 苯唑西林杂质1 舒巴坦杂质19 舒他西林 脱乙酰基戊二酰 7-氨基头孢烷酸 脱乙酰基头孢噻肟 肟莫南 羰苄西林苯酯钠 美罗培南钠盐 美罗培南 美洛培南 缩酮氨苄青霉素 紫杉醇侧链2 硫霉素 硫霉素 硫酸氢3-{[(6R,7R)-7-{[(2E)-2-(2-氨基-1,3-噻唑-4-基)-2-(甲氧基亚氨基)乙酰基]氨基}-2-羧基-8-羰基-5-硫杂-1-氮杂二环[4.2.0]辛-2-烯-3-基]甲基}-1,3-噻唑-3-正离子 硫酸头孢噻利 硫酸头孢喹诺 盐酸巴氨西林 盐酸头孢唑兰 盐酸头孢吡肟 盐酸头孢他美酯 盐酸头孢他美 癸二酸与六氢-2H-氮杂卓-2-酮,1,6-己烷二胺和己二酸的聚合物